Patients & Visitors ›

Profile

Profile
Research

John M. Burkart, M.D.

Professor, Nephrology

Clinical Specialties

Peritoneal Dialysis, Hemodialysis, Clinical Nephrology

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-3963
Department: 336-716-4650

Media Medical Expert »

Insurance Accepted »

Education & Training

M.D., Rush Medical College , 1979
B.S., University of Illinois Administration , 1974
Internship, Medicine, North Carolina Baptist Hospital, 1980
Residency, Medicine, North Carolina Baptist Hospital, 1982
Fellowship, North Carolina Baptist Hospital, 1984

Board Certifications

American Board of Internal Medicine, Nephrology
American Board of Internal Medicine, Internal Medicine

Memberships

Int'L Society Peritoneal Dialy
Am Soc Of Nephrology

NPI Number

1669457891

John M. Burkart, M.D.

Professor, Nephrology

Research Interests

diabetes, drugs/therapeutic agents pharm

Contact Information

Academic: 336-716-3963 | Department: 336-716-4650

Media Medical Expert »

Recent Publications

Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Schiller BM, Yang PC, Rajagopalan S, Burkart J, Moossavi S, Mauck V, Kaufman T, et al. Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Circ Cardiovasc Imaging. 2012;5(2):251-261.

Hall YN, Larive B, Painter P, Kaysen GA, Lindsay RM, Nissenson AR, Unruh ML, Rocco MV, Chertow GM, Burkart J, Moosavi S, Mauck V, Kaufman T, et al. Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials. Clin J Am Soc Nephrol. 2012;7(5):782-794.

Sergeyeva O, Gorodetskaya I, Ramos R, Schiller BM, Larive B, Raimann JG, Ting GO, Eggers PW, Chertow GM, Levin NW, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, Coppley A, et al. Challenges to enrollment and randomization of the Frequent Hemodialysis Network (FHN) Daily Trial. J Nephrol. 2012;25(3):302-309.

Burkart J. Combination therapy: five days PD and one day HD -- what are the benefits?. Contrib Nephrol. 2012;178():216-220.

Warnock DG, Hebbar S, Bargman J, Burkart J, Davies S, Finkelstein FO, Mehrotra R, Ronco C, Teitelbaum I, Urakpo K, Chertow GM. Prospective safety study of bardoxolone methyl in patients with type 2 diabetes mellitus, end-stage renal disease and peritoneal dialysis. Contrib Nephrol. 2012;178():157-163.

Pierce DA, Williamson JC, Mauck VS, Russell GB, Palavecino E, Burkart JM. The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis. Perit Dial Int. 2012;32(5):525-530.

Jaber BL, Schiller B, Burkart JM, Daoui R, Kraus MA, Lee Y, Miller BW, Teitelbaum I, Williams AW, Finkelstein FO. Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances. Clin J Am Soc Nephrol. 2011;6(5):1049-1056.

Vachharajani TJ, Moossavi S, Jordan JR, Vachharajani V, Freedman BI, Burkart JM. Re-evaluating the Fistula First Initiative in octogenarians on hemodialysis. Clin J Am Soc Nephrol. 2011;6(7):1663-1667.

Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T, Burkart J, Moossavi S, Mauck V, Kaufman T, et al. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int. 2011;80(10):1080-1091.

Hawfield AT, Russell GB, Burkart JM, Chandramohan V. Erythropoietin maximum dose reduction protocol for hemodialysis [abstract]. J Am Soc Nephrol. 2011;22(Abstract Suppl):478A.

Unruh ML, Larive B, Chertow GM, Eggers PW, Garg AX, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, et al. Effects of six versus three times per week hemodialysis on depressive affect and mental health: Frequent Hemodialysis Network (FHN) trials [abstract]. J Am Soc Nephrol. 2011;22(Abstract Suppl):255A.

Hall YN, Larive B, Painter PL, Kaysen GA, Lindsay RM, Rocco MV, Burkart J, Moossavi S, Mauck V, Kaufman T, et al. Effects of six versus three times per week hemodialysis on physical performance, health and functioning: Frequent Hemodialysis Network (FHN) trials [abstract]. J Am Soc Nephrol. 2011;22(Abstract Suppl):66A.

Golper TA, Saxena AB, Piraino B, Teitelbaum I, Burkart J, Finkelstein FO, Abu-Alfa A. Systematic barriers to the effective delivery of home dialysis in the United States: a report from the Public Policy/Advocacy Committee of the North American Chapter of the International Society for Peritoneal Dialysis. Am J Kidney Dis. 2011;58(6):879-885.

Freedman BI, Shenoy RN, Planer JA, Clay KD, Shihabi ZK, Burkart JM, Sabio H, Byers JR, Russell GB, Bleyer AJ, et al. Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis. Perit Dial Int. 2010;30(1):72-79.

Burkart J. The future of peritoneal dialysis: PD in 2010 and beyond. Dial Transplant. 2010;39(8):349-353.

Burkart JM. Adequacy of peritoneal dialysis In: Henrich WL, ed. Principles and practice of dialysis. 4th ed. Philadelphia: Wolters Kluwer Health/Lippincott Wiliams & Wilkins;2009: 241-265.

Burkart J. The future of peritoneal dialysis in the United States: optimizing its use. Clin J Am Soc Nephrol. 2009;4(Suppl 1):S125-S131.

Vachharajani TJ, Moossavi S, Daeihgah P, Jordan JR, Coe MS, Burkart JM, Freedman B. Academic free-standing vascular access centers: early experience [abstract]. Semin Dial. 2008;21(1):106.

Vachharajani TJ, Moossavi S, Kaufman TM, Jordan JR, Freedman BI, Burkart JM. Re-evaluating the fistula first initiative in octogenarian dialysis patients [abstract]. J Vasc Access. 2008;9(Suppl 1):S16-S17.

Burkart J. Role of peritoneal dialysis in the era of the resurgence of home hemodialysis. Hemodial Int. 2008;12(Suppl 1):S51-S54.

Burkart JM. Techniques in peritoneal dialysis In: Wilcox CS, ed. Therapy in nephrology & hypertension: a companion to Brenner & Rector's The kidney. 3rd ed. Philadelphia: Saunders/Elsevier;2008: 913-923.

Moossavi S, Russell G, Vachharajani T, Burkart J, Freedman B. Effect of practice pattern on hemodialysis access thrombosis: the impact of access surveillance [abstract]. J Am Soc Nephrol. 2008;19():901A.

Shenoy RN, Planer JA, Clay KD, Bleyer AJ, Burkart JM, Cardona CY, Byers JR, Russell GB, Shihabi ZK, Freedman BI, et al. Evaluation of glycated albumin (GA), HbA1c and serum glucose concentrations in diabetic peritoneal (PD) and hemodialysis (HD) patients [abstract]. J Am Soc Nephrol. 2008;19():974A-975A.

Satko SG, Burkart JM. Initiation of dialysis therapy In: Nissenson AR, Fine RN, eds. Handbook of dialysis therapy. 4th ed. Philadelphia: Saunders/Elsevier;2008: 341-351.

Satko SG, Burkart JM. Determination of continuous ambulatory peritoneal dialysis and automated peritoneal dialysis prescriptions In: Nissenson AR, Fine RN, eds. Handbook of dialysis therapy. 4th ed. Philadelphia: Saunders/Elsevier;2008: 539-548.

Burkart J. Why is the evidence favoring hemodialysis over peritoneal dialysis misleading? [editorial]. Semin Dial. 2007;20(3):200-202.

Moossavi S, Moossavi S, Raasch E, Jordan J, Burkat [sic] J [Burkart J]. Comparison of dialysis access outcomes in peritoneal dialysis (PD) and hemodialysis (HD) patients at an academic medical center [abstract]. J Am Soc Nephrol. 2007;18(Abstracts Issue):466A.

Raasch E, Moossavi S, Beekman D, Russell G, Moossavi S, Jordon J, Mauck V, Burkart J. Comparison of dialysis outcomes in peritoneal dialysis and hemodialysis patients at an academic medical center [abstract]. J Am Soc Nephrol. 2007;18(Abstracts Issue):477A.

Saran A, Moossavi S, Hutchens M, Russell G, Burkart J. Comparison of mean Kt/v and anuric Kt/v in adult peritoneal dialysis (PD) patients based on weight [abstract]. J Am Soc Nephrol. 2007;18(Abstracts Issue):477A.

Saran AM, Moossavi S, Russell G, Kaufman T, Burkart J. Comparison of mean Kt/v and clinical outcomes in an adult peritoneal dialysis (PD) population based on body mass index (BMI) (kg/m2) [abstract]. J Am Soc Nephrol. 2007;18(Abstracts Issue):477A.

Saran A, Moossavi S, Russell G, Mauck V, Burkart J. Comparison of clinical outcomes in an adult PD population with a body mass index (BMI) greater than 30 kg/m2 based on the placement of abdominal or presternal peritoneal dialysis catheters [abstract]. J Am Soc Nephrol. 2007;18(Abstracts Issue):903A.

Moossavi S, Moossavi S, Coe M, Burkart J. Comparison of patient turn over/loss in an academic hemodialysis (HD) unit and peritoneal dialysis (PD) unit [abstract]. J Am Soc Nephrol. 2007;18(Abstracts Issue):918A.

Burkart J. Transitions from PD are expected. Why not continue at home?. Perit Dial Int. 2007;27(6):645-646.

Kraus M, Burkart J, Hegeman R, Solomon R, Coplon N, Moran J. A comparison of center-based vs. home-based daily hemodialysis for patients with end-stage renal disease. Hemodial Int. 2007;11(4):468-477.

Teitelbaum I, Mehrotra R, Golper TA, Burkart JM. Peritoneal dialysis In: Schrier RW, ed. Diseases of the kidney & urinary tract, vol 1. 8th ed. Philadelphia: Lippincott Williams & Wilkins;2007: 2612-2647.

Lo W-K, Bargman JM, Burkart J, Krediet RT, Pollock C, Kawanishi H, Blake PG. Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int. 2006;26(5):520-522.